The Oncosearch | Oncotarget

Low EGFR/MET ratio is associated with resistance to EGFR inhibitors in non-small cell lung cancer Research Paper

Silvia Park, Emma Langley, Jong-Mu Sun, Steve Lockton, Jin Seok Ahn, Anjali Jain, Keunchil Park, Sharat Singh, Phillip Kim, Myung-Ju Ahn

Published Sep 3, 2015 · Vol. 6, No. 31 · pp. 30929-30938

Triple negative breast cancer: looking for the missing link between biology and treatments Research Perspective

Giuseppe Palma, Giuseppe Frasci, Andrea Chirico, Emanuela Esposito, Claudio Siani, Carmela Saturnino, Claudio Arra, Gennaro Ciliberto, Antonio Giordano, Massimiliano Dâ€™Aiuto

Published Aug 30, 2015 · Vol. 6, No. 29 · pp. 26560-26574

18F-fluorodeoxyglucose (FDG) PET/CT after two cycles of neoadjuvant therapy may predict response in HER2-negative, but not in HER2-positive breast cancer Research Paper

Jingyi Cheng, Yujie Wang, Miao Mo, Xiao Bao, Yingjian Zhang, Guangyu Liu, Jun Zhang, Daoying Geng

Published Aug 21, 2015 · Vol. 6, No. 30 · pp. 29388-29395

Digital PCR analysis of plasma cell-free DNA for non-invasive detection of drug resistance mechanisms in EGFR mutant NSCLC: Correlation with paired tumor samples Research Paper

Hidenobu Ishii, Koichi Azuma, Kazuko Sakai, Akihiko Kawahara, Kazuhiko Yamada, Takaaki Tokito, Isamu Okamoto, Kazuto Nishio, Tomoaki Hoshino

Published Aug 17, 2015 · Vol. 6, No. 31 · pp. 30850-30858

Anxa2 binds to STAT3 and promotes epithelial to mesenchymal transition in breast cancer cells Research Paper

Tong Wang, Jie Yuan, Jie Zhang, Ran Tian, Wei Ji, Yan Zhou, Yi Yang, Weijie Song, Fei Zhang, Ruifang Niu

Published Aug 15, 2015 · Vol. 6, No. 31 · pp. 30975-30992

Crocetinic acid inhibits hedgehog signaling to inhibit pancreatic cancer stem cells Research Paper

Parthasarathy Rangarajan, Dharmalingam Subramaniam, Santanu Paul, Deep Kwatra, Kanagaraj Palaniyandi, Shamima Islam, Sitaram Harihar, Satish Ramalinagam, William Gutheil, Sandeep Putty, Rohan Pradhan, Subhash Padhye, Danny R. Welch, Shrikant Anant, Animesh Dhar

Published Aug 13, 2015 · Vol. 6, No. 29 · pp. 27661-27673

The BIM deletion polymorphism is a prognostic biomarker of EGFR-TKIs response in NSCLC: A systematic review and meta-analysis Research Paper

Wei Nie, Xia Tao, Hua Wei, Wan-sheng Chen, Bing Li

Published Jul 27, 2015 · Vol. 6, No. 28 · pp. 25696-25700

⁸⁹Zr-cetuximab PET imaging in patients with advanced colorectal cancer Clinical Research Papers

Catherina Willemien Menke-van der Houven, Elske C Gootjes, Marc C Huisman, Danielle J Vugts, Chantal Roth, Anne Marije Luik, Emma R Mulder, Robert C Schuit, Ronald Boellaard, Otto S Hoekstra, Guus AMS van Dongen, Henk MW Verheul

Published Jul 23, 2015 · Vol. 6, No. 30 · pp. 30384-30393

New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: do all roads lead to RAS? Review

Giuseppe Bronte, Nicola Silvestris, Marta Castiglia, Antonio Galvano, Francesco Passiglia, Giovanni Sortino, Giuseppe Cicero, Christian Rolfo, Marc Peeters, Viviana Bazan, Daniele Fanale, Antonio Giordano, Antonio Russo

Published Jul 22, 2015 · Vol. 6, No. 28 · pp. 24780-24796

Enhanced transfection efficiency and targeted delivery of self-assembling h-R3-dendriplexes in EGFR-overexpressing tumor cells Research Paper

Jun Lia, Shengnan Li, Songyun Xia, Jinfeng Feng, Xuedi Zhang, Yanli Hao, Lei Chen, Xiaoning Zhang

Published Jul 20, 2015 · Vol. 6, No. 28 · pp. 26177-26191

RUNX2 and TAZ-dependent signaling pathways regulate soluble E-Cadherin levels and tumorsphere formation in breast cancer cells Research Paper

Jessica L. Brusgard, Moran Choe, Saranya Chumsri, Keli Renoud, Alexander D. MacKerell Jr., Marius Sudol, Antonino Passaniti

Published Jul 20, 2015 · Vol. 6, No. 29 · pp. 28132-28150

Continuation of epidermal growth factor receptor tyrosine kinase inhibitor treatment prolongs disease control in non-small-cell lung cancers with acquired resistance to EGFR tyrosine kinase inhibitors Research Paper

Qi Chen, Qi Quan, Lingyu Ding, Xiangchan Hong, Ningning Zhou, Ying Liang, Haiying Wu

Published Jul 9, 2015 · Vol. 6, No. 28 · pp. 24904-24911

The downregulation of Î”Np63 in p53-deficient mouse epidermal tumors favors metastatic behavior Research Paper

Olga Bornachea, Fernando F. LÃ³pez-CalderÃ³n, Marta DueÃ±as, Carmen Segrelles, Corina Lorz, Cristian SuÃ¡rez-Cabrera, MarÃa MaraÃ±Ã³n, Beatriz Paradela-Dobarro, Mirentxu Santos, JesÃºs M. Paramio

Published Jul 1, 2015 · Vol. 6, No. 27 · pp. 24230-24245

The pioneer factor PBX1 is a novel driver of metastatic progression in ERÎ±-positive breast cancer Research Paper

Luca Magnani, Darren K. Patten, Van T. M. Nguyen, Sung-Pil Hong, Jennifer H. Steel, Naina Patel, Ylenia Lombardo, Monica Faronato, Ana R. Gomes, Laura Woodley, Karen Page, David Guttery, Lindsay Primrose, Daniel Fernandez Garcia, Jacqui Shaw, Patrizia Viola, Andrew Green, Christopher Nolan, Ian O. Ellis, Emad A. Rakha, Sami Shousha, Eric W.-F. Lam, BalÃ¡zs GyÅ‘rffy, Mathieu Lupien, Charles R. Coombes

Published Jun 15, 2015 · Vol. 6, No. 26 · pp. 21878-21891

A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives Review

Alessandro Russo, Tindara Franchina, Giuseppina Rosaria Rita Ricciardi, Antonio Picone, Giuseppa Ferraro, Mariangela ZanghÃ¬, Giuseppe Toscano, Antonio Giordano, Vincenzo Adamo

Published Jun 12, 2015 · Vol. 6, No. 29 · pp. 26814-26825

Long non-coding RNA UCA1 induces non-T790M acquired resistance to EGFR-TKIs by activating the AKT/mTOR pathway in EGFR-mutant non-small cell lung cancer Research Paper

Ningning Cheng, Weijing Cai, Shengxiang Ren, Xuefei Li, Qi Wang, Hui Pan, Mingchuan Zhao, Jiayu Li, Yishi Zhang, Chao Zhao, Xiaoxia Chen, Ke Fei, Caicun Zhou, Fred R. Hirsch

Published Jun 8, 2015 · Vol. 6, No. 27 · pp. 23582-23593

High EGFR and low p-Akt expression is associated with better outcome after nimotuzumab-containing treatment in esophageal cancer patients: preliminary clinical result and testable hypothesis Clinical Research Papers

Chun-yu Wang, Jia-ying Deng, Xu-wei Cai, Xiao-long Fu, Yuan Li, Xiao-yan Zhou, Xiang-hua Wu, Xi-chun Hu, Min Fan, Jia-qing Xiang, Ya-wei Zhang, Hai-quan Chen, Rolando Perez, Guo-liang Jiang, Kuai-le Zhao

Published Jun 8, 2015 · Vol. 6, No. 21 · pp. 18674-18682

Combined deletion of p38Î³ and p38Î´ reduces skin inflammation and protects from carcinogenesis Priority Research Paper

Rafal Zur, Laura Garcia-Ibanez, Angel Nunez-Buiza, Noelia Aparicio, Georgios Liappas, Alejandra EscÃ³s, Ana Risco, Angustias Page, Cristina Saiz-Ladera, Dayanira Alsina-Beauchamp, JosÃ© Montans, JesÃºs M. Paramio, Ana Cuenda

Published May 28, 2015 · Vol. 6, No. 15 · pp. 12920-12935

Identification of epidermal growth factor receptor and its inhibitory microRNA141 as novel targets of KrÃ¼ppel-like factor 8 in breast cancer Research Paper

Tianshu Li, Heng Lu, Debarati Mukherjee, Satadru K. Lahiri, Chao Shen, Lin Yu, Jihe Zhao

Published May 27, 2015 · Vol. 6, No. 25 · pp. 21428-21442

Erlotinib is effective in pancreatic cancer with epidermal growth factor receptor mutations: a randomized, open-label, prospective trial Clinical Research Papers

Jack P. Wang, Chen-Yi Wu, Yi-Cheng Yeh, Yi-Ming Shyr, Ying-Ying Wu, Chen-Yu Kuo, Yi-Ping Hung, Ming-Huang Chen, Wei-Ping Lee, Jiing-Chyuan Luo, Yee Chao, Chung-Pin Li

Published May 20, 2015 · Vol. 6, No. 20 · pp. 18162-18173

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Low EGFR/MET ratio is associated with resistance to EGFR inhibitors in non-small cell lung cancer Research Paper

Triple negative breast cancer: looking for the missing link between biology and treatments Research Perspective

18F-fluorodeoxyglucose (FDG) PET/CT after two cycles of neoadjuvant therapy may predict response in HER2-negative, but not in HER2-positive breast cancer Research Paper

Digital PCR analysis of plasma cell-free DNA for non-invasive detection of drug resistance mechanisms in EGFR mutant NSCLC: Correlation with paired tumor samples Research Paper

Anxa2 binds to STAT3 and promotes epithelial to mesenchymal transition in breast cancer cells Research Paper

Crocetinic acid inhibits hedgehog signaling to inhibit pancreatic cancer stem cells Research Paper

The BIM deletion polymorphism is a prognostic biomarker of EGFR-TKIs response in NSCLC: A systematic review and meta-analysis Research Paper

⁸⁹Zr-cetuximab PET imaging in patients with advanced colorectal cancer Clinical Research Papers

New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: do all roads lead to RAS? Review

Enhanced transfection efficiency and targeted delivery of self-assembling h-R3-dendriplexes in EGFR-overexpressing tumor cells Research Paper

RUNX2 and TAZ-dependent signaling pathways regulate soluble E-Cadherin levels and tumorsphere formation in breast cancer cells Research Paper

Continuation of epidermal growth factor receptor tyrosine kinase inhibitor treatment prolongs disease control in non-small-cell lung cancers with acquired resistance to EGFR tyrosine kinase inhibitors Research Paper

The downregulation of Î”Np63 in p53-deficient mouse epidermal tumors favors metastatic behavior Research Paper

The pioneer factor PBX1 is a novel driver of metastatic progression in ERÎ±-positive breast cancer Research Paper

A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives Review

Long non-coding RNA UCA1 induces non-T790M acquired resistance to EGFR-TKIs by activating the AKT/mTOR pathway in EGFR-mutant non-small cell lung cancer Research Paper

High EGFR and low p-Akt expression is associated with better outcome after nimotuzumab-containing treatment in esophageal cancer patients: preliminary clinical result and testable hypothesis Clinical Research Papers

Combined deletion of p38Î³ and p38Î´ reduces skin inflammation and protects from carcinogenesis Priority Research Paper

Identification of epidermal growth factor receptor and its inhibitory microRNA141 as novel targets of KrÃ¼ppel-like factor 8 in breast cancer Research Paper

Erlotinib is effective in pancreatic cancer with epidermal growth factor receptor mutations: a randomized, open-label, prospective trial Clinical Research Papers

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Low EGFR/MET ratio is associated with resistance to EGFR inhibitors in non-small cell lung cancer Research Paper

Triple negative breast cancer: looking for the missing link between biology and treatments Research Perspective

18F-fluorodeoxyglucose (FDG) PET/CT after two cycles of neoadjuvant therapy may predict response in HER2-negative, but not in HER2-positive breast cancer Research Paper

Digital PCR analysis of plasma cell-free DNA for non-invasive detection of drug resistance mechanisms in EGFR mutant NSCLC: Correlation with paired tumor samples Research Paper

Anxa2 binds to STAT3 and promotes epithelial to mesenchymal transition in breast cancer cells Research Paper

Crocetinic acid inhibits hedgehog signaling to inhibit pancreatic cancer stem cells Research Paper

The BIM deletion polymorphism is a prognostic biomarker of EGFR-TKIs response in NSCLC: A systematic review and meta-analysis Research Paper

89Zr-cetuximab PET imaging in patients with advanced colorectal cancer Clinical Research Papers

New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: do all roads lead to RAS? Review

Enhanced transfection efficiency and targeted delivery of self-assembling h-R3-dendriplexes in EGFR-overexpressing tumor cells Research Paper

RUNX2 and TAZ-dependent signaling pathways regulate soluble E-Cadherin levels and tumorsphere formation in breast cancer cells Research Paper

Continuation of epidermal growth factor receptor tyrosine kinase inhibitor treatment prolongs disease control in non-small-cell lung cancers with acquired resistance to EGFR tyrosine kinase inhibitors Research Paper

The downregulation of Î”Np63 in p53-deficient mouse epidermal tumors favors metastatic behavior Research Paper

The pioneer factor PBX1 is a novel driver of metastatic progression in ERÎ±-positive breast cancer Research Paper

A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives Review

Long non-coding RNA UCA1 induces non-T790M acquired resistance to EGFR-TKIs by activating the AKT/mTOR pathway in EGFR-mutant non-small cell lung cancer Research Paper

High EGFR and low p-Akt expression is associated with better outcome after nimotuzumab-containing treatment in esophageal cancer patients: preliminary clinical result and testable hypothesis Clinical Research Papers

Combined deletion of p38Î³ and p38Î´ reduces skin inflammation and protects from carcinogenesis Priority Research Paper

Identification of epidermal growth factor receptor and its inhibitory microRNA141 as novel targets of KrÃ¼ppel-like factor 8 in breast cancer Research Paper

Erlotinib is effective in pancreatic cancer with epidermal growth factor receptor mutations: a randomized, open-label, prospective trial Clinical Research Papers

⁸⁹Zr-cetuximab PET imaging in patients with advanced colorectal cancer Clinical Research Papers